| __timestamp | HUTCHMED (China) Limited | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26684000 | 6795238 |
| Thursday, January 1, 2015 | 29829000 | 7454247 |
| Friday, January 1, 2016 | 39578000 | 10345862 |
| Sunday, January 1, 2017 | 43277000 | 16984203 |
| Monday, January 1, 2018 | 48645000 | 16187290 |
| Tuesday, January 1, 2019 | 52934000 | 9299233.54 |
| Wednesday, January 1, 2020 | 61349000 | 19232000 |
| Friday, January 1, 2021 | 127125000 | 23611000 |
| Saturday, January 1, 2022 | 136106000 | 26700000 |
| Sunday, January 1, 2023 | 133175999 | 28215000 |
Unveiling the hidden dimensions of data
In the dynamic world of pharmaceuticals, understanding spending patterns is crucial. Over the past decade, HUTCHMED (China) Limited and Summit Therapeutics Inc. have showcased distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. HUTCHMED's SG&A expenses have surged by nearly 400% from 2014 to 2023, reflecting its aggressive expansion strategy. In contrast, Summit Therapeutics has seen a more modest increase of approximately 315% over the same period.
These trends underscore the strategic priorities of each company, with HUTCHMED focusing on rapid expansion and Summit maintaining a steady growth path.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and HUTCHMED (China) Limited
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Merus N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for HUTCHMED (China) Limited and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: HUTCHMED (China) Limited vs Amphastar Pharmaceuticals, Inc. Trends and Insights